Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Lacto-N-neotetraose.
Lacto-N-neotetraose is a neutral human milk oligosaccharide that functions as a selective prebiotic substrate for Bifidobacteria and a decoy receptor for enteric pathogens to modulate mucosal immunity.
439223
224.38 g/mol
5.1
3,7,11-trimethyldodeca-6,10-dien-1-ol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Lacto-N-neotetraose across standard consumer modalities.
The hygroscopic nature of LNnT necessitates the use of HPMC capsules and moisture-barrier packaging to prevent powder caking.
Thermal processing and acidic pH in gummy production can trigger Maillard reactions or partial hydrolysis of the tetrasaccharide chain.
The high therapeutic dose required for prebiotic efficacy far exceeds the limited volumetric payload capacity of thin-film delivery systems.
Ready to launch a product featuring Lacto-N-neotetraose? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Lacto-N-neotetraose extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Lacto-N-neotetraose payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation